David Hemingway
Impact in
- Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Nitric Oxide and Endothelin Effects 9
-
- Pulmonary Hypertension Research and Treatments 3
- Co-authors
- Andreas J. Gescher (5 shared papers)William P. Steward (5 shared papers)Aisha Shafayat (1 shared paper)Timothy H. Marczylo (1 shared paper)Munir Pirmohamed (1 shared paper)Simon Plummer (1 shared paper)Bruno Morgan (1 shared paper)Darren N. Cooke (1 shared paper)
- Journals
- The International Journal of Biological Markers (6 papers)Journal of Surgical Oncology (3 papers)Clinical Cancer Research (2 papers)Cancer Research (2 papers)Colorectal Disease (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
David Hemingway
26 papers receiving 2.2k citations
David Hemingway's Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Medicine 897
- Geriatrics and Gerontology 273
- Biochemistry 165
- Pharmacology 264
- Pharmacology 132
Countries citing papers authored by David Hemingway
This map shows the geographic impact of David Hemingway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hemingway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hemingway more than expected).
Fields of papers citing papers by David Hemingway
This network shows the impact of papers produced by David Hemingway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hemingway. The network helps show where David Hemingway may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hemingway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Clinical Trial of Oral Curcumin Hit paper breakdown → | 2004 | 1049 |
| 2 | 2010 | 491 | |
| 3 | 2001 | 175 | |
| 4 | 2006 | 132 | |
| 5 | 2012 | 95 | |
| 6 | 2009 | 92 | |
| 7 | 1987 | 53 | |
| 8 | 2004 | 23 | |
| 9 | 2000 | 22 | |
| 10 | 2007 | 21 | |
| 11 | 2004 | 18 | |
| 12 | 2004 | 17 | |
| 13 | 2004 | 15 | |
| 14 | 2010 | 14 | |
| 15 | 2016 | 14 | |
| 16 | 2015 | 12 | |
| 17 | 2012 | 10 | |
| 18 | 2014 | 10 | |
| 19 | 2002 | 9 | |
| 20 | 2002 | 8 |
About David Hemingway
David Hemingway is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Molecular Biology, having authored 27 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (9 papers), Pulmonary Hypertension Research and Treatments (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal and Anal Carcinomas (2 papers), Curcumin's Biomedical Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Molecular Medicine (897 citations), Geriatrics and Gerontology (273 citations), Biochemistry (165 citations), Pharmacology (264 citations) and Pharmacology (132 citations). David Hemingway has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Andreas J. Gescher, William P. Steward, Aisha Shafayat, Timothy H. Marczylo, Munir Pirmohamed, Simon Plummer, Bruno Morgan, Darren N. Cooke, Ricky A. Sharma and Karen Brown. Their work appears in journals such as The International Journal of Biological Markers, Journal of Surgical Oncology, Clinical Cancer Research, Cancer Research and Colorectal Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.